Multimorbidity is common and associated with adverse outcomes in heart failure (HF). However, its prognostic value across frailty states is uncertain, particularly whether comorbidities continue to stratify risk once frailty develops.
To evaluate whether frailty modifies the association of multimorbidity i...
V. Copeland, B. Fishman, S. Elimelech et al.· European Heart Journal· 0 citations
AI-derived CV biological age from FoCUS identifies subclinical cardiometabolic vulnerability independent of chronological age in asymptomatic adults, and may enhance personalized risk profiling and guide early preventive interventions in asymptomatic adults.
R. Amster, D. Simanovsky, R. Loutati et al.· European Heart Journal· 0 citations
Artificial intelligence (AI)-based left ventricular ejection fraction (LVEF) estimation compares reasonably well with conventional readings. We assessed its prognostic value in the standard transthoracic echocardiography (TTE) and point-of-care-ultrasound (POCUS) settings.
AI-based LVEF estimation was retr...
K. Faierstein, R. Loutati, M. Fiman et al.· European Heart Journal· 0 citations
Assessment of left ventricular diastolic dysfunction (LVDD) and filling pressure is standard in echocardiography but remains time- and expertise-dependent. We evaluated the performance and prognostic significance of an artificial intelligence (AI)-enabled echocardiography for LVDD grading.
An AI model was...
R. Loutati, M. Fiman, A. Amshalom et al.· European Heart Journal· 0 citations
Patients with advanced chronic kidney disease (CKD) and heart failure (HF) are systematically underrepresented in clinical trials despite comprising a substantial proportion of real-world HF populations [1]. Whether contemporary care has translated into improved outcomes in this high-risk group particularly among...
D. Hochstein, D. Sternik, V. Copeland et al.· European Heart Journal· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.